Neutral with upside potential. Oscar Health (
OSCR) is at $20.41, down 0.34% daily but up 36.43% monthly, as shown in the finance card above. X posts highlight strong bullish sentiment, with a weekly wedge breakout and high volume fueling optimism for a move toward $25-$30. Fundamentals are solid, with 42% Q1 2025 revenue growth, $1.2B net cash, and 660% EPS growth projected for 2025. However, volatility (13% weekly) and a downgrade to Market Perform by Raymond James (price target cut to $18) signal caution. Support is at $19.50-$20; resistance is at $21.36-$23.79. A breakout above $21.36 could target $25, but earnings concerns and a high valuation (255% premium per Morningstar) cap near-term upside
OSCR) is at $20.41, down 0.34% daily but up 36.43% monthly, as shown in the finance card above. X posts highlight strong bullish sentiment, with a weekly wedge breakout and high volume fueling optimism for a move toward $25-$30. Fundamentals are solid, with 42% Q1 2025 revenue growth, $1.2B net cash, and 660% EPS growth projected for 2025. However, volatility (13% weekly) and a downgrade to Market Perform by Raymond James (price target cut to $18) signal caution. Support is at $19.50-$20; resistance is at $21.36-$23.79. A breakout above $21.36 could target $25, but earnings concerns and a high valuation (255% premium per Morningstar) cap near-term upside
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.